<html>
<head>PUBMED IDs for SCRN1</head>
<body bgcolor='#C5F0F2'><h1>SCRN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16367923/'>Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.</a> December 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16630140/'>Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray.</a> April 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20039278/'>SCRN1 is a novel marker for prognosis in colorectal cancer.</a> March 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23829175/'>Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24098497/'>Concurrent gene signatures for han chinese breast cancers.</a> July 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25399950/'>A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.</a> October 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25399948/'>Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).</a> March 25  2014<br></body></html>
